STOCK TITAN

Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DexCom, Inc. (NASDAQ:DXCM) announced that CEO Kevin Sayer will present at the 40th annual J.P. Morgan Healthcare Conference on January 10, 2022, starting at approximately 10:30 AM EST. The virtual presentation will be webcasted, and interested parties can access it through the DexCom Investor Relations website. DexCom is a leader in diabetes care technology, focusing on innovative continuous glucose monitoring (CGM) systems to improve diabetes management worldwide.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 40th annual J.P. Morgan Healthcare Conference on January 10, 2022.

The live presentation, which will occur virtually, is scheduled to begin at approximately 10:30 AM EST and will be concurrently webcast.

The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations.”

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.

DexCom, Inc.

Sean Christensen

Senior Director – Investor Relations and Corporate FP&A

(858) 203-6657

Source: DexCom, Inc.

FAQ

When will DexCom present at the J.P. Morgan Healthcare Conference?

DexCom will present on January 10, 2022, at approximately 10:30 AM EST.

Who is presenting for DexCom at the conference?

Kevin Sayer, the CEO of DexCom, will be the presenter.

How can I watch the DexCom presentation?

The presentation will be webcasted and can be accessed via the DexCom Investor Relations website.

What does DexCom specialize in?

DexCom specializes in innovative continuous glucose monitoring systems for diabetes management.

Where is DexCom headquartered?

DexCom is headquartered in San Diego, California.

DexCom, Inc.

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

30.57B
400.73M
0.32%
100.93%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO